Training

Register now

Virtual meeting

Via Zoom

Description

This training will review strategies to reduce communicable infectious diseases associated with injection drug use; testing strategies and linkage to care for those patients with diagnosed blood-borne pathogens; bleaching/sterilization of injection paraphernalia, serosorting or sequential drug use to prevent infection of uninfected partners; and pharmacological interventions for infection prevention including nPEP and PrEP.

The harm reduction series is a 10-part education series for healthcare providers and SUD treatment programs to better understand Harm Reduction principles and harm reduction strategies as best practice in SUD treatment. The series will provide participants with an hour long didactic with a 30 minute Q+A. Each session is taught by an educator from the Grayken TTA team and an expert community member with boots on the ground experience in the specific topic area. Participants may attend all sessions or select specific courses. Continuing education credits are offered for each session.

Intended audience

Medical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and members of the community.

Speakers

Annie Potter, MSN, MPH, NP, CARN-AP (she/her)

Annie is a clinical nurse educator for Boston Medical Center's Grayken Center for Addiction Training and Technical Assistance, an assistant professor of medicine at Boston University Chobanian & Avedisian School of Medicine, and a nurse practitioner at Boston Medical Center. Annie contributes to peer-reviewed publications, evidence-based clinical guidelines, development and delivery of continuing education programs, and other resources for clinicians supporting patients with substance use disorders. Annie is also consultant and educator for the Massachusetts HEALing Communities Study, a multi-state study funded by the National Institute on Drug Abuse. She is also the Medical Director for the Massachusetts Community Health Center ECHO and an expert faculty member of the Provider Clinical Support System Exchange (PCSS-X). Annie's other clinical interests include treatment and prevention of HIV and Hepatitis C, family planning, and care for gender-diverse individuals. Before joining Boston Medical Center, Annie practiced at a community health center in Baltimore, MD, where she established and directed the city's first walk-in HIV treatment and prevention program. She is board-certified in addictions and holds specialty certifications for the treatment of HIV and Hepatitis C. Annie earned both her Master of Nursing and Master of Public Health from Johns Hopkins University.

Joseph Shay

Objectives

Following this training, participants will have the knowledge necessary to:

• Recall communicable infections associated with injection drug use
• Evaluate strategies to reduce the risk of communicable infections for people who inject drugs
• Identify at least 2 behavioral interventions to reduce the risk of HIV transmission associated with injection practices
• Identify at least 2 pharmacological interventions for communicable disease acquisition among patients who inject drugs
• Name at least 3 vaccines recommended for the prevention of infections for people who inject drugs

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Boston Medical Center grants 1.50 hours to all nurses who attend and complete the evaluation. Boston Medical Center is approved as a provider of nursing continuing professional development by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

As a Jointly Accredited Organization, Boston University Chobanian & Avedisian School of Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.50 general continuing education credits.

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 1.50 contact hours will be offered to participants who attend the training and complete the evaluation.

Register now